These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 31412233

  • 1. RISK FACTORS FOR HEARING IMPAIRMENT IN TYPE 1 DIABETES.
    Braffett BH, Lorenzi GM, Cowie CC, Gao X, Bainbridge KE, Cruickshanks KJ, Kramer JR, Gubitosi-Klug RA, Larkin ME, Barnie A, Lachin JM, Schade DS, DCCT/EDIC Research Group.
    Endocr Pract; 2019 Dec; 25(12):1243-1254. PubMed ID: 31412233
    [Abstract] [Full Text] [Related]

  • 2. Hearing Impairment and Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    Schade DS, Lorenzi GM, Braffett BH, Gao X, Bainbridge KE, Barnie A, Cruickshanks KJ, Dalton D, Diminick L, Gubitosi-Klug R, Kramer JR, Lachin JM, Larkin ME, Cowie CC, DCCT/EDIC Research Group.
    Diabetes Care; 2018 Dec; 41(12):2495-2501. PubMed ID: 30254082
    [Abstract] [Full Text] [Related]

  • 3. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
    [Abstract] [Full Text] [Related]

  • 4. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, Timothy Garvey W, Lyons TJ, DCCT/EDIC Research Group.
    Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
    [Abstract] [Full Text] [Related]

  • 5. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER, Adkins L, Loader CJ, Han H, Rice KM, Denvir J, Driscoll HK.
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [Abstract] [Full Text] [Related]

  • 6. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Lachin JM, Orchard TJ, Nathan DM, DCCT/EDIC Research Group.
    Diabetes Care; 2014 Feb; 37(1):39-43. PubMed ID: 24356596
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [Abstract] [Full Text] [Related]

  • 8. The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study.
    Orchard TJ, Lyons TJ, Cleary PA, Braffett BH, Maynard J, Cowie C, Gubitosi-Klug RA, Way J, Anderson K, Barnie A, Villavicencio S, DCCT/EDIC Research Group.
    Diabetes Care; 2013 Oct; 36(10):3146-53. PubMed ID: 23813757
    [Abstract] [Full Text] [Related]

  • 9. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Cleary PA, Braffett BH, Orchard T, Lyons TJ, Maynard J, Cowie C, Gubitosi-Klug RA, Way J, Anderson K, Barnie A, Villavicencio S, DCCT/EDIC Research Group.
    Diabetes Technol Ther; 2013 Jun; 15(6):466-74. PubMed ID: 23882708
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
    Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S, Diabetes Control and Complications Trial, Epidemiology of Diabetes Interventions and Complications Research Group.
    N Engl J Med; 2003 Jun 05; 348(23):2294-303. PubMed ID: 12788993
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, Garvey WT, Lyons TJ, DCCT/EDIC Research Group.
    Atherosclerosis; 2016 Jan 05; 244():93-100. PubMed ID: 26600440
    [Abstract] [Full Text] [Related]

  • 19. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
    Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, Genuth S, DCCT/EDIC Research Group.
    Cardiovasc Diabetol; 2015 Sep 05; 14():118. PubMed ID: 26341632
    [Abstract] [Full Text] [Related]

  • 20. Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I, Braffett BH, Orchard TJ, Lorenzi GM, Lachin JM, DCCT/EDIC Research Group.
    Diabetes Care; 2019 Jul 05; 42(7):1284-1289. PubMed ID: 30894365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.